Acurx Pharmaceuticals Stock Forecast - Simple Regression
| ACXP Stock | USD 2.75 0.03 1.08% |
The Simple Regression forecasted value of Acurx Pharmaceuticals LLC on the next trading day is expected to be 2.21 with a mean absolute deviation of 0.30 and the sum of the absolute errors of 18.42. Acurx Stock Forecast is based on your current time horizon. Although Acurx Pharmaceuticals' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Acurx Pharmaceuticals' systematic risk associated with finding meaningful patterns of Acurx Pharmaceuticals fundamentals over time.
As of today the rsi of Acurx Pharmaceuticals' share price is below 20 . This suggests that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
EPS Estimate Next Quarter (1.38) | EPS Estimate Current Year (5.71) | EPS Estimate Next Year (3.71) | Wall Street Target Price 61.7 | EPS Estimate Current Quarter (1.49) |
Using Acurx Pharmaceuticals hype-based prediction, you can estimate the value of Acurx Pharmaceuticals LLC from the perspective of Acurx Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors.
The Simple Regression forecasted value of Acurx Pharmaceuticals LLC on the next trading day is expected to be 2.21 with a mean absolute deviation of 0.30 and the sum of the absolute errors of 18.42. Acurx Pharmaceuticals after-hype prediction price | USD 2.75 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Acurx Pharmaceuticals to cross-verify your projections. Acurx Pharmaceuticals Additional Predictive Modules
Most predictive techniques to examine Acurx price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Acurx using various technical indicators. When you analyze Acurx charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Acurx Pharmaceuticals Simple Regression Price Forecast For the 25th of January
Given 90 days horizon, the Simple Regression forecasted value of Acurx Pharmaceuticals LLC on the next trading day is expected to be 2.21 with a mean absolute deviation of 0.30, mean absolute percentage error of 0.16, and the sum of the absolute errors of 18.42.Please note that although there have been many attempts to predict Acurx Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Acurx Pharmaceuticals' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Acurx Pharmaceuticals Stock Forecast Pattern
| Backtest Acurx Pharmaceuticals | Acurx Pharmaceuticals Price Prediction | Buy or Sell Advice |
Acurx Pharmaceuticals Forecasted Value
In the context of forecasting Acurx Pharmaceuticals' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Acurx Pharmaceuticals' downside and upside margins for the forecasting period are 0.03 and 9.61, respectively. We have considered Acurx Pharmaceuticals' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Regression forecasting method's relative quality and the estimations of the prediction error of Acurx Pharmaceuticals stock data series using in forecasting. Note that when a statistical model is used to represent Acurx Pharmaceuticals stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 118.0991 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.2971 |
| MAPE | Mean absolute percentage error | 0.0786 |
| SAE | Sum of the absolute errors | 18.4173 |
Predictive Modules for Acurx Pharmaceuticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Acurx Pharmaceuticals LLC. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Acurx Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Acurx Pharmaceuticals After-Hype Price Prediction Density Analysis
As far as predicting the price of Acurx Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Acurx Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Acurx Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Acurx Pharmaceuticals Estimiated After-Hype Price Volatility
In the context of predicting Acurx Pharmaceuticals' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Acurx Pharmaceuticals' historical news coverage. Acurx Pharmaceuticals' after-hype downside and upside margins for the prediction period are 0.14 and 10.15, respectively. We have considered Acurx Pharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Acurx Pharmaceuticals is dangerous at this time. Analysis and calculation of next after-hype price of Acurx Pharmaceuticals LLC is based on 3 months time horizon.
Acurx Pharmaceuticals Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Acurx Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Acurx Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Acurx Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
1.18 | 7.40 | 5.69 | 6.50 | 7 Events / Month | 6 Events / Month | In about 7 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
2.75 | 2.75 | 0.00 |
|
Acurx Pharmaceuticals Hype Timeline
Acurx Pharmaceuticals LLC is presently traded for 2.75. The entity has historical hype elasticity of -5.69, and average elasticity to hype of competition of -6.5. Acurx is anticipated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is about 153.53%. The immediate return on the next news is anticipated to be very small, whereas the daily expected return is presently at -1.18%. %. The volatility of related hype on Acurx Pharmaceuticals is about 134.28%, with the expected price after the next announcement by competition of -3.75. The company has price-to-book (P/B) ratio of 1.65. Some equities with similar Price to Book (P/B) outperform the market in the long run. Acurx Pharmaceuticals LLC recorded a loss per share of 8.18. The entity had not issued any dividends in recent years. The firm had 1:20 split on the 5th of August 2025. Given the investment horizon of 90 days the next anticipated press release will be in about 7 days. Check out Historical Fundamental Analysis of Acurx Pharmaceuticals to cross-verify your projections.Acurx Pharmaceuticals Related Hype Analysis
Having access to credible news sources related to Acurx Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict Acurx Pharmaceuticals' future price movements. Getting to know how Acurx Pharmaceuticals' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Acurx Pharmaceuticals may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| APRE | Aprea Therapeutics | (0.11) | 8 per month | 0.00 | (0.27) | 4.40 | (8.40) | 17.87 | |
| ADIL | Adial Pharmaceuticals | 0.00 | 0 per month | 0.00 | (0.18) | 5.56 | (6.25) | 16.67 | |
| BCDA | Biocardia | (0.06) | 8 per month | 0.00 | (0.04) | 5.93 | (5.76) | 21.46 | |
| HCWB | HCW Biologics | (0.50) | 8 per month | 0.00 | (0.20) | 13.02 | (11.97) | 41.72 | |
| GLTO | Galecto | (28.66) | 2 per month | 7.03 | 0.13 | 17.97 | (14.66) | 273.14 | |
| CELZ | Creative Medical Technology | (0.26) | 9 per month | 0.00 | (0.08) | 9.31 | (11.22) | 50.90 | |
| KPRX | Kiora Pharmaceuticals | (0.04) | 6 per month | 0.00 | (0.08) | 5.32 | (6.25) | 21.80 | |
| INAB | In8bio Inc | 0.02 | 4 per month | 4.77 | 0.05 | 14.29 | (9.18) | 37.96 | |
| APVO | Aptevo Therapeutics | (25.38) | 4 per month | 0.00 | (0.25) | 7.81 | (9.42) | 45.42 | |
| BCLI | Brainstorm Cell Therapeutics | (0.12) | 6 per month | 0.00 | (0.06) | 9.09 | (6.67) | 24.01 |
Other Forecasting Options for Acurx Pharmaceuticals
For every potential investor in Acurx, whether a beginner or expert, Acurx Pharmaceuticals' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Acurx Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Acurx. Basic forecasting techniques help filter out the noise by identifying Acurx Pharmaceuticals' price trends.Acurx Pharmaceuticals Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Acurx Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Acurx Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Acurx Pharmaceuticals by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Acurx Pharmaceuticals Market Strength Events
Market strength indicators help investors to evaluate how Acurx Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Acurx Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Acurx Pharmaceuticals stock market strength indicators, traders can identify Acurx Pharmaceuticals LLC entry and exit signals to maximize returns.
| Accumulation Distribution | 4871.86 | |||
| Daily Balance Of Power | (0.13) | |||
| Rate Of Daily Change | 0.99 | |||
| Day Median Price | 2.78 | |||
| Day Typical Price | 2.77 | |||
| Price Action Indicator | (0.04) | |||
| Period Momentum Indicator | (0.03) |
Acurx Pharmaceuticals Risk Indicators
The analysis of Acurx Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Acurx Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting acurx stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 4.6 | |||
| Standard Deviation | 7.15 | |||
| Variance | 51.16 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Acurx Pharmaceuticals
The number of cover stories for Acurx Pharmaceuticals depends on current market conditions and Acurx Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Acurx Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Acurx Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Acurx Pharmaceuticals Short Properties
Acurx Pharmaceuticals' future price predictability will typically decrease when Acurx Pharmaceuticals' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Acurx Pharmaceuticals LLC often depends not only on the future outlook of the potential Acurx Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Acurx Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 851.5 K | |
| Cash And Short Term Investments | 3.7 M |
Additional Tools for Acurx Stock Analysis
When running Acurx Pharmaceuticals' price analysis, check to measure Acurx Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Acurx Pharmaceuticals is operating at the current time. Most of Acurx Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Acurx Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Acurx Pharmaceuticals' price. Additionally, you may evaluate how the addition of Acurx Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.